SMART INVESTORS CASHING IN ON POT COM

New Post Public Reply Private Reply Replies (1) Message Board
CherylShuman

SMART INVESTORS CASHING IN ON POT COM BOOM~!!!!!

http://www.thedailybeast.com/newsweek/2012/10...at%20Sheet

Content Section

In Newsweek Magazine

The New Pot Barons

Oct 22, 2012 1:00 AM EDT

Pot use in the United States is rising sharply, and voters may make it fully legal in two states this fall. Smart businessmen are banking on that happening.

Full dark in downtown Denver, and inside one of the twinkling high-rises that make the skyline, drug dealers are putting money into envelopes. They’re trying to be discreet. No one signed the security logbook in the lobby. All assume the room could be bugged. But if your image of the drug trade involves armed gangs or young men in parked cars, these dealers offer a surreal counterpoint. There’s a finance veteran, two children of the Ivy League, multiple lawyers, and the son of a police chief. At their side is a Pulitzer Prize–winning communications consultant, two state lobbyists, and a nationally known political operative. And the guest of honor: a state senator who likes the look of those envelopes being stuffed.

Colorado Marijuana

Grows are carefully tended—from climate and lighting down to the music that’s piped in. (Andrew Hetherington for Newsweek)

“What’s the maximum contribution?” one of the dealers asks. “Do you take cash?” wonders another. A third man breaks into a smile. “You better,” he says, eyebrows dancing, “because the banks don’t like doing business with us.” Laughter fills the room as the envelopes are passed forward and slipped into a briefcase. “Huge thank you, everyone,” the politician says, guiding the conversation back to the next legislative session and the kinds of legal changes this group would like to see. Here again, it’s not what you’d expect: there’s talk of a youth drug-abuse-prevention program and a bill to define “drugged” driving. When the politician finally rises to leave, after more than an hour, the dealers, in their pressed shirts and suit jackets, clap heartily. The average participant looks to be about 35, white and male, and on good terms with a barber. “Thank you,” the politician says, bowing slightly. “Thank you for what you do.”

What they do is sell marijuana. And not on street corners. Colorado is the developed world’s only regulated for-profit cannabis market, and sales—to the 100,000 residents who have a thumbs up from their M.D.s—are closing in on $200 million this year, a sum that generates tens of millions of dollars in local, state, and federal taxes. (Yes, the IRS taxes marijuana operations, even as the Justice Department attempts to shut them down.) Colorado is not the world’s only experiment in free-market pot, but it’s the most sophisticated, pushing beyond the Netherlands’ confusing ban on wholesale and California’s hazy nonprofit status. Denver’s former city attorney has called it California “on steroids.”

While the cannabis market remains illegal under federal law, attitudes are changing quickly, and it’s that fact that the Colorado growers are banking on. The number of regular pot users is up by 3 million in the past five years, and the rate of high-school experimentation is at a 30-year high. When a kid first lights up at about age 16, it’s usually not with a cigarette. Twelve states now treat a personal stash like a minor traffic offense, 17 allow medical marijuana, and this Election Day, if current polls hold, voters in Washington State and Colorado will vote to legalize marijuana—not for medical purposes but, as Rolling Stone recently enthused, “for getting-high purposes.”

That would close out a 40-year fight launched by boomers and carried through by a big tent of talented reformers, growing bigger all the time. “Weed is the new gay,” says Ted Trimpa, a Democratic strategist who helped engineer Colorado’s flip from red state to blue. He’s now focused on marijuana reform. But what I saw in Colorado was something altogether new: self-described “social entrepreneurs,” the Sergey Brins and Mark Zuckerbergs of the Green Rush. They could have done almost anything with their lives—“my brother is a physician” is the kind of thing one hears from them—but they chose to enter the pot business because they see it as a boom market, miracle cure, and social movement decades in the making and suddenly, thrillingly, near.

“This is our Facebook,” says one of my hosts, Norton Arbelaez, the owner of two dispensaries and a commercial grow. “This is the same kind of environment, the same kind of setting, and the same kind of people.” He was a founding member of the Medical Marijuana Industry Group (MMIG), a powerful young lobby that’s buried the age of drum-circle activism and instead strives to partner with law enforcement and politicians. It was their board meeting in the high-rise downtown, a weekly gathering two blocks from the Capitol dome. And it is their goal to dress legal pot in a style as conservative as their own.

(Page 2 of 4)

That’s why they offered Newsweek unprecedented access. While the organization is officially neutral on legalization, many of its members privately support it and believe their example demonstrates that the drug most of the world knows as “herbal cannabis” can be regulated, taxed, and safely sold. “This is a botanical blockbuster,” says Arbelaez, with a half-ironic flourish. That is, if it’s not shut down by the federal government before the lobby can win mainstream acceptance. “We’re the tortoise, not the hare,” says Arbelaez. “But the tortoise wins, eventually.”

Colorado Marijuana

Old-school American pot was smuggled in and dirty. This was a beautiful, and explicitly professional, product. (Andrew Hetherington for Newsweek)

Heading West toward the Rocky Mountains, Denver rises like a city in a snow globe, but before you reach the exits for downtown, there’s a stark industrial ring, a hard-hat zone of freight trains, heavy equipment, and all-purpose warehouse space. This is home to Colorado’s pot business, housed in at least a million square feet—more than all the office space in the city’s tallest skyscraper. Over the course of two bright, warm days this month, accompanied by members of MMIG’s self-described “nerd herd” of pot entrepreneurs, I toured three of these warehouses.

They are each as boring as a soundstage until the moment one actually sees the plants. One second you’re in the gray, empty cold of a warehouse, your mind hypnotized by the dull hum of electricity. The next you’re standing in a perfect simulacrum of summer sunshine with hundreds of gorgeous green plants gently waving, stirred by fans and soothed by classical music (or energized by hard rock, depending on what the master grower says the plant “likes”).

It’s always harvest time in some of these rooms. Always processing time in others. A magic garden with no sun or bugs. Old-school American pot, smuggled in by boat or plane, was dirty: doused in ocean spray, soaked in fuel, or infested with spiders. This is a beautiful, and explicitly professional, product: hundreds of acorn-size buds flecked with crystals of THC, the chemical without which these plants might as well be ferns.

“Look at this fat boy,” says Arbelaez, cupping the flowering buds of a short, stocky plant. “Ain’t that beautiful?” I nodded. His whole operation had an aesthetic to it, with different seasons being replicated inside different rooms and a team of growers acting as botanical gods: thanks to sensors in each growing room, if the conditions slip, the plant minders get a text message.

But the most impressive space was the one in sync with the natural world, a stand of marijuana plants fed by natural light through the roof, the pot leaves looming up overhead, casting shadows. Arbelaez appears over my shoulder. “What are you writing down?” he asks. I show him the page. “BIG TREES,” it says, and he laughs, bending down to wrap his hand around a three- or four-inch trunk. “That is a tree, bro.”

Arbelaez came to Colorado with Jon Salfeld, a friend from Tulane Law School. The two are a bit of an odd couple. Arbelaez is tall, olive-skinned, and voluble. The son of a General Motors assembly-line worker, he went to the University of Oklahoma on scholarship and came out comfortable in a suit. Salfeld is shorter and more soft-spoken. The son of a lawyer, he went to Cornell—by way of Manhattan—and came out with hair to his collar. Walking around Denver with them, with Salfeld’s eyes on his BlackBerry and Arbelaez’s on everything else, sometimes felt like a night out with a tour manager and his talent.

But there’s no doubt they have a bond. After meeting at Tulane, they recognized a shared enthusiasm for marijuana, and after graduation in 2006, they roomed together, working uninspiring jobs in medical malpractice and real estate. Then the economy collapsed. Salfeld lost his job. And in the hands-on-head discussions of what opportunities might emerge, Arbelaez suggested pot in Colorado. “I didn’t even know if was legal out there,” says Salfeld. They researched it and found a compelling case: good weather, a pot-friendly population, and a strong legal footing.

They arrived in the summer of 2009, just a few weeks before an Obama administration memo steered law enforcement away from medical marijuana shops in “unambiguous compliance” with state laws. Overnight thousands of people galloped into business. Colorado soon had more pot shops than Starbucks, and a two-mile stretch of Broadway became a thicket of smoke-in-your-face entrepreneurs. Bikini girls hawked $5 joints, bums in sandwich boards advertised two-for-one ounces, and former black-market dealers reportedly dragged their trash bags of weed into the light.


(Page 3 of 4)

It was as troubling a scene as Arbelaez and Salfeld could imagine. Unless legal weed was done properly—with rules and regulations and clean-shaven owners in suits—they knew the effort was doomed. So they joined up with other marijuana entrepreneurs to help pass Bill 1284: a controversial, seed-to-sale framework for controlling the industry. It banned felons and in many cases put up six-figure barriers to entry. The licensing alone cost as much as $18,000, necessary to help fund a special-enforcement division. As much as half the industry was wiped out by the new rules. Salfeld even lost a store, deemed too close to another that predated his. But it was all necessary. As even law-enforcement officials admit, it created the basis for safe and limited legal weed in America.

Colorado Marijuana

Official “budtenders” sell the drug in pills, sodas, chocolate, hot dogs, and, of course, bud. (Andrew Hetherington for Newsweek)

Owner operators like Salfeld and Arbelaez are now working hard to uphold those standards, each pouring more than a million dollars into their operations, much of it compliance-related. “There’s no bulls--t,” says Arbelaez. In the grow houses, there are security cameras, inventory reports, and detailed delivery systems accounting for every gram of pot, from every plant, all accessible to Colorado authorities 24 hours a day. Their biggest concern in agreeing to this article was an almost genteel respect for law enforcement. “We’re about transparency,” says Arbelaez. “We’re about trust.”

But there’s only so much the industry can do to legitimize itself right now. Every morning outside the unmarked bottling factory, home to Dixie Elixirs, America’s first multistate cannabis-infused-soda maker, men in suits hold the door for 20-somethings in spider-web-patterned skullcaps and sweatpants. I met Salfeld’s highest-paid employee, his master grower, Joe, wearing flannel pajama pants and a “420 Weed” T-shirt, as he threw out a doughnut box. Arbelaez’s careful tour was interrupted by the arrival of one of his trimmers, the wizard-bearded host of a Web show called “Tokin.” All the best talent is de facto, developed in violation of federal law.

And this tension between the shadowy roots of pot and the direct light of legalization pervades the industry, which employs more than 4,000 people in Colorado, hundreds of them in six-figure jobs. At River Rock, Arbelaez’s two-store operation, and Local Product of Colorado, Salfeld’s upmarket boutique, more than 100 people are on staff. Fleets of contractors collecting checks cycle through, along with gardening wholesalers, business consultants, and software developers. The whole state has been buoyed by marijuana sales without evident decay.

But because Arbelaez and Salfeld, and the rest of the industry, are technically felonious under federal law, they struggle for basic business services. Banks and landlords hesitate to take their money. They can’t get traditional loans, or insurance, or health coverage. Credit-card companies won’t process transactions in their stores. Judges won’t enforce their contracts. The IRS forbids normal business deductions, bankrupting many operations. But that’s the only deduction allowed. “Not a whole lot of money is being made,” says Arbelaez. “We’ve all had sleepless nights,” adds Salfeld. “We’ve all had scares.”

This in-between nature of the business is present in the very product, too. Does medicinal pot help people? Absolutely. It eases pain and nausea, generates appetite, encourages sleep, and generally comforts the seriously afflicted. Yet it’s also a euphoric drug that parks itself in a part of the brain named after the Sanskrit word for “bliss.” It’s both—a medicine you like to take—which is why some patients with pot prescriptions have cancer or glaucoma, but others are young to middle-aged men with vague complaints of pain. “Skateboarders with bruises,” is the running aside from critics.

The prescribing of medical marijuana is also a bit of a slapstick routine. Oh, you have cancer? Try this wonder medicine called Pineapple Grenade or Alien Dog or Face Wreck. Oh, you have a doctor’s recommendation? Try smoking this dab of hash with a butane torch, some foil, and what looks like a crack pipe. And then there are the festivals, so-called cannabis cups that blend the sobriety of a bar crawl with the crowd behavior of the Adult Video News awards, all doctor-approved. Sometimes there’s even a doctor on site writing scrips. “It can be very, very annoying,” says Salfeld of these more antisocial aspects of his market. But just inside the door of his flagship store, two blocks from the Denver Art Museum, is a five-foot-tall bonglike trophy: an industry award for “patient” care.


Rapid Fire Marketing, Inc. (RFMK) Stock Research Links

RFMK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JIMMY's Nespure N9: Innovating Coffee and Clean Water

Updated Category News Views 2

Unpacking JIMMY's Latest Innovation at IFA Every now and then, something comes along that makes you think, "Why didn't I think of that?" Well, JIMMY just hit that nail square on the head with its latest concoction—the Nespure N9. Debuting at the IFA 2026 in Berlin, this little gizmo combines water purification with coffee brewing, all from a modestly-sized countertop...

Continue Reading
CRESYN Opens Model Residence: A Peek at City Living

Updated Category News Views 0

CRESYN: Urban Elegance Hits Long Island City Who doesn't want to peek under the hood when a flashy new ride rolls into town? CRESYN's newly unveiled model residence in Long Island City is just that—an invitation to get up close and personal with what modern urban living can be. Forget the blueprints and glossy renderings. This place is the real deal, giving you that...

Continue Reading
Yardi Virtuoso AI to Shine at CAIC 2026 Toronto

Updated Category News Views 3

The Scene in Toronto: Yardi's Big AI Showcase There's no denying it—Artificial Intelligence has muscled its way into practically every corner of the business world, and now it's making waves in real estate. Yardi, a familiar name in real estate tech circles, is gearing up to flaunt its Yardi Virtuoso Enterprise at the Canadian Apartment Investment Conference (CAIC) in...

Continue Reading
Regeneron: Investors Face Class Action Over Study Flaws

Updated Category News Views 3

Regeneron Investors Grit Teeth Amid Lawsuit Drama The gloves are off in the pharmaceutical battleground, folks. Investors who thought they were riding the big wave with Regeneron Pharmaceuticals (NASDAQ: REGN) are now staring down the barrel of a class action lawsuit. It seems the company’s been caught in a storm of legal action following allegations of misleading...

Continue Reading
Haier and UEFA's Deal: A Game-Changer for Fans?

Updated Category News Views 1

A Bold Play in the Global Arena There's something big brewing on the horizon, as Haier aligns with the UEFA Champions League. From 2027 to 2031, this move isn't just about slapping a logo on a jersey. Nah, it's more than that. Haier's stepping up its game, aiming to become a real player in weaving technology and sports into the daily lives of millions. "We aim to bring...

Continue Reading
What to Expect from KeyCorp at Barclays Event

Updated Category News Views 1

KeyCorp's Next Move: An Insider's View Yep, circle that calendar, folks. Looks like KeyCorp's gonna be laying it all out there for the financial world to see. Clark Khayat, their numero uno money guy, is hitting the stage at the Barclays Global Financial Services Conference on Sept. 14. So grab the popcorn—or, more like, your portfolio tracker—because this could get...

Continue Reading
Curaleaf Expands in Florida Amid Rising Cannabis Demand

Updated Category News Views 0

Curaleaf's Bold Moves in Florida's Ganja Gold Rush Fresh out of the gate, Curaleaf is saddling up for a wild ride into Florida's cannabis frontier. They've just thrown open the doors of their latest dispensary in Riverview, cranking their statewide count up to 77. Now, isn’t that something? If you're tracking these folks, you know that bringing their nationwide total to...

Continue Reading
ECRI Welcomes Safety Expert Meshkati to Its Board

Updated Category News Views 1

The Safety Maverick Steps into Healthcare They've gone and done it—appointed a rockstar of systems safety to ECRI's Board of Trustees. Professor Najmedin Meshkati, who's practically been around every major industrial accident of the past few decades, is about to shake things up. Imagine the guy who's dissected calamities like the BP Texas City Refinery explosion and the...

Continue Reading
Innovation Drives New Asia-Pacific Opportunities

Updated Category News Views 1

A Glimpse Into The Future: Asia-Pacific's Tech Landscape There's a unique transformation bubbling across the Asia-Pacific scene, with young minds pushing the envelope on technology and innovation. Take Nathapol's team from Thailand, for example. They're merging bionic tech with drones for disaster relief—bold, ambitious, and nearly clinching glory at the Lancang-Mekong...

Continue Reading
Better's 90-Day Plan: Growth Amidst Governance Gamble

Updated Category News Views 3

Unpacking the Ambitious 90-Day Plan When you hear Vishal Garg's name next to a 90-day sprint plan, it's not your everyday boardroom shuffle—you know there's grit behind the screen. Better Home & Finance (BETR) is angling for a massive turnaround with its latest rollout, but whether it's all sizzle and no steak is what we're here to figure out. Financial Metrics and...

Continue Reading

Top 5 Most Recently Viewed Articles

Automotive Bushing Market Expected to Exceed $264 Billion

Updated Category News Views 140

Automotive Bushing Market Overview The Automotive Bushing Market is anticipated to reach USD 264.30 billion by 2032, experiencing a compound annual growth rate (CAGR) of 5.14% from 2024 to 2032. This growth is largely attributed to the rising demand for higher-end vehicles in emerging markets. As consumers increasingly seek comfort and performance, there is a noticeable...

Continue Reading
Select Water Solutions Engages in Fireside Chat Series

Updated Category News Views 100

Select Water Solutions to Join Fireside Chat Series Select Water Solutions, Inc. (NYSE: WTTR) is a key player in offering sustainable water and chemical solutions tailored for the energy sector. Recently, the company announced their participation in the Water Tower Research Fireside Chat Series, featuring two of their top executives, Chris George, who serves as the...

Continue Reading
Innovative Partnership Unveils New Potential in CNS Treatments

Updated Category News Views 194

Lynk Pharmaceuticals and Formation Bio Partnership Lynk Pharmaceuticals Co., Ltd. and Formation Bio have recently entered into an exclusive development and licensing agreement regarding LNK01006. This exciting collaboration opens up new avenues for treatment focused on enhancing central nervous system health. Understanding LNK01006 LNK01006 is a notable innovation,...

Continue Reading
Cloud Capital Announces Successful Close of Fund II Investment

Updated Category News Views 170

Cloud Capital Fund II Achieves Final Close, Attracting Investors Cloud Capital, a prominent name in global data center investment management, has announced a significant milestone with the completion of the final close for Cloud Capital Fund II. This closed-end investment vehicle is focused on strategizing and acquiring high-quality data centers, highlighting its...

Continue Reading
Analyzing Investor Sentiments Toward Paycom Software

Updated Category News Views 169

Understanding Short Interest in Paycom Software Paycom Software's short percent of float has increased to 4.63% as indicated in its latest report, reflecting a total of 2.22 million shares sold short. This equates to approximately 4.75% of the company's available shares for trading. On average, it currently takes traders about 4.75 days to cover their short positions...

Continue Reading